NO171312C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-substituerte 1-alkylamino-2-propanoler - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-substituerte 1-alkylamino-2-propanoler

Info

Publication number
NO171312C
NO171312C NO885081A NO885081A NO171312C NO 171312 C NO171312 C NO 171312C NO 885081 A NO885081 A NO 885081A NO 885081 A NO885081 A NO 885081A NO 171312 C NO171312 C NO 171312C
Authority
NO
Norway
Prior art keywords
alkylamino
present
propanols
substituted
preparation
Prior art date
Application number
NO885081A
Other languages
English (en)
Other versions
NO171312B (no
NO885081D0 (no
NO885081L (no
Inventor
Nicholas S Bodor
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of NO885081D0 publication Critical patent/NO885081D0/no
Publication of NO885081L publication Critical patent/NO885081L/no
Publication of NO171312B publication Critical patent/NO171312B/no
Publication of NO171312C publication Critical patent/NO171312C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32Oximes
    • C07C251/34Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/36Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/38Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
NO885081A 1987-03-16 1988-11-15 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-substituerte 1-alkylamino-2-propanoler NO171312C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2600287A 1987-03-16 1987-03-16
PCT/US1988/000386 WO1988007036A1 (en) 1987-03-16 1988-02-16 LABILE KETONE DERIVATIVES OF 3-SUBSTITUTED-1-ALKYLAMINO-2-PROPANOLS AND THEIR USE AS beta-ADRENERGIC BLOCKERS

Publications (4)

Publication Number Publication Date
NO885081D0 NO885081D0 (no) 1988-11-15
NO885081L NO885081L (no) 1989-01-13
NO171312B NO171312B (no) 1992-11-16
NO171312C true NO171312C (no) 1993-02-24

Family

ID=21829283

Family Applications (1)

Application Number Title Priority Date Filing Date
NO885081A NO171312C (no) 1987-03-16 1988-11-15 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-substituerte 1-alkylamino-2-propanoler

Country Status (14)

Country Link
EP (1) EP0283147B1 (no)
JP (2) JPH01501797A (no)
KR (1) KR960008766B1 (no)
AT (1) ATE105547T1 (no)
AU (1) AU609788B2 (no)
CA (1) CA1335286C (no)
DE (2) DE3889486T4 (no)
DK (1) DK626588A (no)
ES (1) ES2051831T3 (no)
FI (1) FI94337C (no)
IE (1) IE62828B1 (no)
NO (1) NO171312C (no)
WO (1) WO1988007036A1 (no)
ZA (1) ZA881226B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988007036A1 (en) * 1987-03-16 1988-09-22 University Of Florida LABILE KETONE DERIVATIVES OF 3-SUBSTITUTED-1-ALKYLAMINO-2-PROPANOLS AND THEIR USE AS beta-ADRENERGIC BLOCKERS
US5177064A (en) * 1990-07-13 1993-01-05 University Of Florida Targeted drug delivery via phosphonate derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3619370A (en) * 1969-04-21 1971-11-09 Frosst & Co Charles E Microbial reduction of thiadiazoles
DE2645710C2 (de) * 1976-10-09 1985-06-27 Merck Patent Gmbh, 6100 Darmstadt Phenoxy-amino-propanole, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung
JPS563862A (en) * 1979-06-26 1981-01-16 Nippon Denso Co Refrigeration device
IL65541A0 (en) * 1981-05-06 1982-07-30 Haessle Ab Alkylamino-2-propanols,process for their preparation and pharmaceutical preparations containing same
US4521414A (en) * 1981-06-18 1985-06-04 The Texas A&M University System Ophthalmic compositions and their use for treating elevated intraocular pressure and glaucoma
DE3270905D1 (en) * 1981-12-17 1986-06-05 Haessle Ab Para-substituted 3-phenoxy-1-carbonylaminoalkylamino-propan-2-ols having beta receptor blocking properties
US4616022A (en) * 1984-08-17 1986-10-07 Warner-Lambert Company Procaterol stabilization
WO1988007036A1 (en) * 1987-03-16 1988-09-22 University Of Florida LABILE KETONE DERIVATIVES OF 3-SUBSTITUTED-1-ALKYLAMINO-2-PROPANOLS AND THEIR USE AS beta-ADRENERGIC BLOCKERS

Also Published As

Publication number Publication date
IE880475L (en) 1988-09-16
DE3889486T2 (de) 1994-09-01
KR960008766B1 (ko) 1996-07-03
NO171312B (no) 1992-11-16
JPH06122624A (ja) 1994-05-06
FI885271A0 (fi) 1988-11-15
JPH0518820B2 (no) 1993-03-15
ZA881226B (en) 1988-08-17
EP0283147A1 (en) 1988-09-21
FI94337B (fi) 1995-05-15
NO885081D0 (no) 1988-11-15
JPH01501797A (ja) 1989-06-22
ES2051831T3 (es) 1994-07-01
AU1345988A (en) 1988-10-10
IE62828B1 (en) 1995-03-08
DK626588A (da) 1988-12-08
EP0283147B1 (en) 1994-05-11
DE3889486D1 (de) 1994-06-16
DK626588D0 (da) 1988-11-10
CA1335286C (en) 1995-04-18
ATE105547T1 (de) 1994-05-15
FI885271A (fi) 1988-11-15
WO1988007036A1 (en) 1988-09-22
DE3889486T4 (de) 1994-12-01
KR890700573A (ko) 1989-04-25
FI94337C (fi) 1995-08-25
AU609788B2 (en) 1991-05-09
NO885081L (no) 1989-01-13

Similar Documents

Publication Publication Date Title
DE3564941D1 (en) Dihydropyridazinones
PT74626A (en) Process for preparing 9-<2-(3-indolyl)ethyl>-1-oxa-4,9-diazas- piro<5,5>undecan-3-ones
NO156203C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 6alfa-methylprednisolon-derivater.
KR910016915A (ko) 과콜레스테롤혈증 치료제
HK1012423A1 (en) Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase
NO161564C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-oxadiazolylderivater.
CA2321188A1 (en) Derivatives of azetidine and pyrrolidine
CA2042113A1 (en) Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors
PH24176A (en) New bicyclic compounds,process for preparation thereof and pharmaceutical composition comprising the same
NO171312C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-substituerte 1-alkylamino-2-propanoler
HUT49879A (en) Process for producing new 1',2'-dihydrospiro square brackets open imidazolidine-4,4'(3'h)-quinoline square brackets closed derivatives and pharmaceutical compositions comprising these compounds as active ingredient
NO161493C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,6-nafthyridinderivater.
NO178025C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive (benzhydryloksyetylpiperidyl)alifatiske syrederivater
IE811212L (en) Substituted phenoxy-aminopropanol derivatives
SE8302452D0 (sv) Method for treatment of senile dementia
JPS5579372A (en) Preparation of carbostyril derivative
AU9021882A (en) I-furyl-3,4-dihydroisoquinolines
AU657423B2 (en) Novel piperidine derivatives and process for preparation thereof
NO177931C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive piperazinderivater
NO914201L (no) Fremgangsmaate ved fremstilling av 4 (1h) quinolonderivater

Legal Events

Date Code Title Description
MK1K Patent expired